It’s not just Big Pharma looking to a fast-growing China for help in growing its own bottom line. Chinese pharmaceutical companies are working toward the same thing. And for both groups, the optimism could be justified. In fact, Chinese pharma stocks were up yesterday on news out of China’s annual meeting of the National People’s Congress. At the meeting, officials have reiterated their ambitions for expanding health insurance coverage and improving medical care. For pharma, the idea is that a.) as the government spends more, spending on drugs will grow commensurately, and b.) that as the government modernizes and improves medical care, more Chinese will forego traditional herbal remedies in favor of prescription drugs. Drugmakers from all